NCT05960578 2026-03-12
Golimumab and Apalutamide for the Treatment of Castration-Resistant Prostate Cancer, TRAMP Study
University of Washington
Phase 2 Active not recruiting
Clinical Trials
3 trialsNCT04729296 2021-12-02
Anti-TNFα to Delay or Prevent Progression to Stage 3 T1D
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Phase 2 Withdrawn
NCT01715896 2016-10-31
A Study of Mavrilimumab Versus Anti Tumor Necrosis Factor in Subjects With Rheumatoid Arthritis
MedImmune LLC
Phase 2 Completed